Large-scale testing (Phase 3)Looking for participantsNCT06568367
What this trial is testing
Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
Who this might be right for
Excessive SleepinessShift-work Disorder
Axsome Therapeutics, Inc. 520